Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Claims and disclaimers: whose expertise counts?

Linda F Hogle¹

¹Stanford University Center for Biomedical Ethics, 701 Welch Rd., Suite 1105-A, Palo Alto, CA 94304, USA. lhogle@stanford.edu

Medical Anthropology

|December 3, 2002

Summary

This study examines how the Food and Drug Administration (FDA) regulatory processes shift medical expertise. It explores how patient consumerism impacts knowledge domains and authority in pharmaceutical decision-making.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Accounting for accountable care: Value-based population health management.

Social studies of science·2019

Same author

The social production of evidence: regenerative medicine and the 21st Century Cures Act.

Regenerative medicine·2017

Same author

Allying with donors to link health and medical information with stem cell lines can advance disease modeling while enhancing data access.

Cell stem cell·2014

Same author

Recommendations for nanomedicine human subjects research oversight: an evolutionary approach for an emerging field.

The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics·2013

Same author

Concepts of risk in nanomedicine research.

The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics·2013

Same author

Characterizing human embryonic stem cells: biological and social markers of identity.

Medical anthropology quarterly·2011

Area of Science:

Medical Anthropology
Sociology of Science
Health Policy

Background:

Interactions between state, clinical, scientific, and lay participants shape illness understandings.
Competing knowledge claims challenge jurisdictional authority and expertise definitions.
The Food and Drug Administration (FDA) regulatory processes are central to negotiating knowledge domains.

Purpose of the Study:

To examine social processes in knowledge domain negotiation and sustenance across authority boundaries.
To analyze shifting roles of commercial interests, patient groups, and agencies in defining health problems.
To investigate the redefinition of medical expertise with patient-as-consumer models for pharmaceuticals.

Main Methods:

Qualitative analysis of regulatory processes at the Food and Drug Administration (FDA).
Examination of information circulation regarding prescription drugs.
Case study approach focusing on shifting roles and responsibilities in health problem management.

Main Results:

New information circulation modes are altering the roles of commercial interests, patient groups, and federal agencies.
Patient-as-consumer models challenge traditional gatekeepers like physicians and insurance plans.
The locus of risk, responsibility, credibility, and authority in pharmaceutical decisions is being reconfigured.

Conclusions:

The definition and practice of medical expertise are evolving due to shifts in pharmaceutical information and decision-making.
Regulatory processes must adapt to new dynamics of knowledge, authority, and expertise in healthcare.
Understanding these shifts is crucial for navigating contemporary health landscapes and patient empowerment.

Related Experiment Videos